Akèy › Kansè nan tete › New York › Buffalo
Etid klinik pou Kansè nan tete nan Buffalo, NY
16 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Buffalo (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
Ap rekriteVolontè an sante akeyi
- Roswell Park Cancer Institute, Buffalo
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 2
- Roswell Park Cancer Institute IDS, Buffalo
Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
Ap rekriteFaz 2
- Roswell Park Comprehensive Cancer Center, Buffalo
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
Ap rekriteFaz 2
- Roswell Park Comprehensive Cancer Center, Buffalo
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Ap rekriteFaz 3
- Roswell Park Cancer Institute, Buffalo
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Ap rekriteFaz 1
- Roswell Park Comprehensive Cancer Center, Buffalo
Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Cancer
Ap rekrite
- Roswell Park Cancer Institute, Buffalo
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Ap rekriteFaz 2
- Roswell Park Cancer Institute, Buffalo
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Ap rekriteFaz 3
- Roswell Park Cancer Institute, Buffalo
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
Ap rekriteFaz 1/2
- Roswell Park Cancer Institute, Buffalo
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
Ap rekrite
- Buffalo General Medical Center, Buffalo
A Patient Navigation Program for Addressing Disparities in Breast Cancer Care
Ap rekrite
- Roswell Park Comprehensive Cancer Center, Buffalo
A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York
Ap rekrite
- Roswell Park Cancer Institute, Buffalo
Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors
Ap rekriteEtid obsèvasyon
- Roswell Park Cancer Institute, Buffalo
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Ap rekriteEtid obsèvasyon
- Massive Bio SYNERGY-AI site, Buffalo
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Ap rekriteEtid obsèvasyon
- Roswell Park Cancer Institute, Buffalo
Etid Kansè nan tete nan lòt vil
- New York City, NY136 etid
- Houston, TX126 etid
- Boston, MA112 etid
- Nashville, TN81 etid
- Los Angeles, CA73 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Queens, NY64 etid
- Durham, NC64 etid
- Chicago, IL59 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan Buffalo
- Kansè Poumon ki pa ti selil19 etid
- Kansè (tout kalite)19 etid
- Leksemi mieloïd egi19 etid
- Kansè poumon16 etid
- Kansè ovè13 etid
- Kansè Metastatik11 etid
- Kansè pwostat11 etid
- Melanom10 etid
- Myelom Miltip10 etid
- Obèsite9 etid
- Limfòm Burkitt8 etid
- Sendwòm myelodisplastik8 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.